UnitedHealth Beans Quest Diagnostics
Updated from Oct. 3
UnitedHealth (UNH) sure knows how to play hardball.
Just ask Quest Diagnostics (DGX), the largest provider of clinical lab services in the country. This week, Quest lost out on a national contract with UnitedHealth -- a company that accounts for 7% of its revenue -- because, it said, "the terms and conditions that were offered by UnitedHealth would have been irresponsible for us to accept."
Competing LabCorp (LH) felt differently and scooped up the 10-year, $3 billion contract for itself.For Quest, which was favored by experts to land the huge deal, the news brought immediate pain. The company's shares plummeted 11% to $54.02. In comparison, LabCorp looked like a big winner with its stock up 3.5% to $67.50. Meanwhile, UnitedHealth itself was up fractionally as the company went about doing its business of driving hard bargains and impressing Wall Street. "UnitedHealth promised in their last investor day that they were going to get $300 million worth of medical cost savings over time," notes Sheryl Skolnick, senior vice president of CRT Capital group. "That comes from hospitals, physicians, labs -- you name it. This is just one step in that direction." At this point, UnitedHealth seems compelled to step all over any party that tries to stand in its away. Recently, for example, UnitedHealth refused to pay higher rates to some HCA (HCA) hospitals even though those facilities have become "out-of-network" -- pushing UnitedHealth policyholders elsewhere -- as a result. Meanwhile, the company has slashed its payments to giant institutional pharmacy operator Omnicare (OCR) as well.
Select the service that is right for you!COMPARE ALL SERVICES
Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
- Weekly roundups
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Upgrade/downgrade alerts
Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.
- Diversified model portfolio of dividend stocks
- Alerts when market news affect the portfolio
- Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.
- Real Money + Doug Kass Plus 15 more Wall Street Pros
- Intraday commentary & news
- Ultra-actionable trading ideas
Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.
- 100+ monthly options trading ideas
- Actionable options commentary & news
- Real-time trading community
- Options TV